Published in Pharmazie on September 01, 1988
Pulse oximetry used for documenting oxygen saturation and right-to-left shunting immediately after birth. Eur J Pediatr (1990) 1.16
Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase. Clin Pharmacol Ther (1981) 1.05
Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. Int J Clin Pharmacol Biopharm (1978) 1.03
Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol (1998) 0.97
Color vision deficiencies: a common sign of intoxication in chronically digoxin-treated patients. J Cardiovasc Pharmacol (1980) 0.96
[A rare complication of percutaneous endoscopic gastrostomy: metastasis of adenocarcinoma of the stomach in the area of the gastric stoma]. Z Gastroenterol (1993) 0.94
Determination of the R(-)- and S(+)-enantiomers of gamma-vinyl-gamma-aminobutyric acid in human body fluids by gas chromatography--mass spectrometry. J Chromatogr (1983) 0.91
Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. J Hepatol (1996) 0.90
Assay of gamma-vinyl-gamma-aminobutyric acid (4-amino-hex-5-enoic acid) in plasma and urine by automatic amino acid analysis. Application to human pharmacokinetics. J Chromatogr (1984) 0.90
Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol. Eur J Clin Pharmacol (1998) 0.87
Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver. J Cancer Res Clin Oncol (1987) 0.86
Limitations of forehead pulse oximetry. J Clin Monit (1995) 0.85
[The pharmacokinetics of bendamustine (Cytostasane) in humans]. Pharmazie (1985) 0.85
Limitations of pulse oximetry. Lancet (1988) 0.82
Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study. Scand J Urol Nephrol (1995) 0.80
[Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a]. Z Gastroenterol (1994) 0.79
[Prognostic relevance of hepatitis C virus genotype for responsiveness to interferon-alpha]. Z Gastroenterol (1995) 0.79
What Google® knows about the pollen season. Allergy (2011) 0.79
Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation. J Med Virol (1996) 0.78
Cloning, expression, and characterization of a chitinase gene from the Antarctic psychrotolerant bacterium Vibrio sp. strain Fi:7. Extremophiles (2001) 0.77
Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine (1999) 0.77
Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin. Eur J Clin Pharmacol (1988) 0.77
Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG positive patients. Transplant Proc (1991) 0.77
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha. J Hepatol (1991) 0.77
Recurrent hepatitis C infection after orthotopic liver transplantation. Transplant Proc (1995) 0.77
Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant (1994) 0.77
[Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage]. Urologe A (1994) 0.76
Absolute bioavailability of oral immediate and slow release fluphenazine in healthy volunteers. Eur J Clin Pharmacol (1996) 0.76
Reflectance pulse oximetry in neonates. Eur J Obstet Gynecol Reprod Biol (1995) 0.75
Intrapartum reflectance pulse oximetry: effects of sensor location and fixation duration on oxygen saturation readings. J Clin Monit (1997) 0.75
Calibration of a reflectance pulse oximeter in fetal lambs for arterial oxygen saturations below 70%. J Soc Gynecol Investig (1998) 0.75
Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew. Agents Actions (1994) 0.75
Capillary blood, dried on filter paper, as sample for monitoring cyclosporin A concentrations. Clin Chem (1987) 0.75
[The bioequivalence of two oral propafenone preparations]. Arzneimittelforschung (1995) 0.75
[Pharmacologic comparative studies of the derivatives of alpha,alpha-diphenyl-alpha-(2-ethylbutoxy)-acetic acid-(beta-dimethylaminoethyl)ester]. Acta Biol Med Ger (1969) 0.75
[Current status of treatment for chronic viral hepatitis using recombinant interferon alpha]. Dtsch Med Wochenschr (1994) 0.75
[Micromethod for determination of theophylline/caffeine and chloramphenicol in plasma with HPLC]. Pharmazie (1991) 0.75
Kinetics of fenoximone, a new cardiotonic, in healthy subjects. Clin Pharmacol Ther (1984) 0.75
A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. J Cardiovasc Pharmacol (1984) 0.75
Effect of theophylline on the riboflavin-sensitized photodegradation of bilirubin in vitro. Biol Neonate (1980) 0.75
[Absolute bioavailability of chlorpromazine, promazine and promethazine]. Arzneimittelforschung (1994) 0.75
Arch Gynecol Obstet (1995) 0.75
[Prescription of selected drugs in ambulatory practice. 1. Penicillin, chloramphenicol and nitrofuran preparations]. Dtsch Gesundheitsw (1973) 0.75
[Disorders of the ability to distinguish colors during digitalis therapy (author's transl)]. MMW Munch Med Wochenschr (1980) 0.75
[Are Doppler methods appropriate for the study of adaptive maternal central circulation regulation in pregnancy?]. Ultraschall Med (1990) 0.75
[Therapy of heart failure using digitalis]. Dtsch Med Wochenschr (1980) 0.75
Investigation of glucose-6-phosphatase in the liver of the human fetus. Int J Biol Res Pregnancy (1982) 0.75
[Teaching of clinical pharmacology in East Germany medical schools]. Farmakol Toksikol (1983) 0.75
Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response. Clin Pharmacol Ther (1987) 0.75
[Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha]. Z Gastroenterol (1990) 0.75
[Absolute bioavailability of digoxin. Comparison of a soft gelatin capsule with a commercial silicic acid matrix preparation]. MMW Munch Med Wochenschr (1982) 0.75
Differences in the bioavailability of dihydrotachysterol preparations. Eur J Clin Pharmacol (1994) 0.75
Comparative bioavailability of two carbamazepine tablets. Int J Clin Pharmacol Ther Toxicol (1983) 0.75
[Drug therapy between possibility and necessity]. Z Arztl Fortbild (Jena) (1983) 0.75
[Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)]. Arzneimittelforschung (1979) 0.75
Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin. J Cardiovasc Pharmacol (1982) 0.75
Evaluation of the efficacy of a combined formulation (Grippostad-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial. Int J Clin Pharmacol Ther (2003) 0.75
[On pharmacology of a series of phenylalkylamines]. Acta Biol Med Ger (1967) 0.75
Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinaemia, and chronic hepatitis C. Lancet (1993) 0.75
[Drug combinations]. Z Arztl Fortbild (Jena) (1977) 0.75
[Pharmacodynamic effects of withasomnin and 2 withasomnin derivatives]. Pract Otorhinolaryngol (Basel) (1971) 0.75
[A micromethod for determining piroxicam concentration in the blood]. Pharmazie (1988) 0.75
Clinical pharmacology in the GDR: the development and present situation. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Investigation of drugs in ambulant patients. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
[Results of conversion from conventional immunosuppressive therapy to cyclosporin A in complications following kidney transplantation]. Z Urol Nephrol (1990) 0.75
Effect of repeated therapeutic doses of digoxin on relative red and green sensitivity detected by Nagel's anomaloscope in healthy trichromats. Dev Ophthalmol (1984) 0.75
Effect of diprafenone on the pharmacokinetics of digoxin. Eur J Clin Pharmacol (1996) 0.75
[Are Doppler methods suitable for the study of adaptive maternal central circulatory regulation in pregnancy? II. Assessment of time parameters and determination of minute distance, conclusions]. Ultraschall Med (1991) 0.75
[Quantitative determination and kinetics of dihydralazine in hypertension patients]. Pharmazie (1985) 0.75
[Reliability and limitations of pulse oximetry in corrective cyanotic heart surgery]. Anaesthesist (1989) 0.75
[Distribution and kinetics of nitrofurantoin in early pregnancy]. Int J Clin Pharmacol (1972) 0.75
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]. Z Gastroenterol (1992) 0.75
[Pharmacology of L- and DL-oxyfedrin]. Pharmazie (1972) 0.75
Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent. Eur J Clin Pharmacol (1996) 0.75
Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonist. Clin Pharmacol Ther (1983) 0.75
[Drug use and patient behavior during pregnancy]. Z Arztl Fortbild (Jena) (1980) 0.75
[Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]. Z Arztl Fortbild (Jena) (1992) 0.75
[Permanent catheter in the porcine ear]. Monatsh Veterinarmed (1973) 0.75
Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated. J Eur Acad Dermatol Venereol (2010) 0.75
Divergent influences of Ca2+ on the action of several cardiotonic steroids in isolated heart muscle preparations. Eur J Pharmacol (1974) 0.75
[On the pharmacology of a series of diphenylaminopropane derivatives]. Pharmazie (1973) 0.75
[Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction]. Beitr Infusionsther (1992) 0.75
Drugs in pregnancy - a prospective study. Int J Biol Res Pregnancy (1982) 0.75
[Animal experiment studies on the susceptibility of AH 3 intoxication]. Dtsch Gesundheitsw (1966) 0.75
[Primary sclerosing cholangitis (PSC)--humoral immune phenomena, pathogenetic aspects and therapeutic possibilities]. Z Gastroenterol (1993) 0.75
The estimation of drug plasma levels in epileptics. Int J Clin Pharmacol Biopharm (1978) 0.75
[Methodologic aspects of determination of ranitidine in plasma with HPLC]. Pharmazie (1991) 0.75
On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin. Eur J Clin Pharmacol (1983) 0.75
[Long-term therapy of chronic cardiac insufficiency using enoximone]. Dtsch Med Wochenschr (1987) 0.75
Incidence and clinical relevance of recurrent hepatitis C infection after orthotopic liver transplantation. Transpl Int (1994) 0.75
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation. Transplantation (1994) 0.75
[Blood level oriented ambulatory cyclosporin A therapy following kidney transplantation]. Z Urol Nephrol (1985) 0.75
Enzymatic activity in carbohydrate metabolism in human liver during development. Int J Biol Res Pregnancy (1982) 0.75
[Drug dependence in working women]. Z Gesamte Hyg (1975) 0.75
[Pharmacokinetics of metronidazole during short-term therapy of trichomoniasis urogenitalis]. Zentralbl Gynakol (1977) 0.75
[The work of Friedrich Loeffler in Greifswald]. Arch Exp Veterinarmed (1978) 0.75
Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T. Int J Clin Pharmacol Biopharm (1978) 0.75